Actelion raises guidance, reports 1H13 earnings

Actelion Ltd. (SIX:ATLN) raised its core earnings guidance on Thursday, attributing the move to sales and earnings being "ahead of the comparable period last year" and the company's cost savings initiative. The European biotech said it now expects core earnings to have double-digit growth in 2013 and to be "at least at the same level" as for 2014, with at least single-digit growth in 2015. Actelion previously expected flat growth in 2013 and single-digit growth in 2014, with double-digit growth by 2015. ...